Company Overview of DrugAbuse Sciences, Inc.
DrugAbuse Sciences, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of alcohol and drug addictions. It offers Naltrexone Depot, a sustained-release formulation of Naltrexone for the treatment of alcohol and opiate addictions; DAS-431 for the treatment of cocaine addiction; and Buprenorphine Depot, a sustained-release formulation of buprenorphine for the treatment of heroin and various opiate addictions. The company was founded in 1994 and is based in Menlo Park, California with an additional office in Paris, France.
1430 Obrien Drive
Menlo Park, CA 94025
Founded in 1994
Key Executives for DrugAbuse Sciences, Inc.
Similar Private Companies By Industry
|Aurogen Incorporated||United States|
|Dynova Laboratories, LLC||United States|
|Stat-Trade, Inc.||United States|
|Vaccinex, Inc.||United States|
|NeuroTherapeutics Pharma, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact DrugAbuse Sciences, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.